CEC

The Clinical Trial Centre (CEC) performs clinical studies. CEC has dedicated facilities and updated ophthalmological equipment. Clinical patient-oriented research involves characterizing disease progression and testing new discoveries by carrying out carefully controlled research studies in patients, i. e., clinical trials. This includes testing not only new drugs, but also new methods, devices, imaging and surgical procedures as well as well-designed prospective, observational, longitudinal studies.

SERVICES
  • Randomized clinical trials
  • Clinical research studies
  • Testing new drugs, methods, devices, imaging and surgical procedures
  • Prospective, observational, longitudinal studies.

The Clinical Trial Centre (CEC) performs clinical trials and studies with special emphasis on
ophthalmology, focusing on patient’s wellbeing. Clinical patient-oriented research involves characterizing disease progression and testing new discoveries by carrying out controlled research studies in patients, i. e., clinical trials. This includes testing not only new drugs, but also new methods, devices, imaging and surgical procedures as well as well-designed prospective, non-interventional, longitudinal studies. Our research is focused on age-related eye diseases with special emphasis on diabetic retinopathy and age-related macular degeneration.

CEC has proven expertise with relevant scientific publications in these areas and is a certified Clinical Site of Excellence by the EVICR.net – European Vision Institute Clinical Research Network since 2006. CEC has experienced and qualified staff and dedicated facilities to perform clinical research according to ICH GCP Guidelines and Data Protection compliant. In its daily routine, CEC uses an Electronic Medical Record integrated with the equipment’s imaging allowing a quick and easy access to the patient’s data.

Research Focus

Biomarkers of progression of Diabetic Retinopathy Vision Threatening Complications in Diabetic Retinopathy Progression Epidemiological characterization of AMD. Characterization of progression of AMD from intermediate to late forms of AMD Evaluation of novel treatment options for complications of Diabetic Retinopathy Validation Outcomes and testing treatments for sight threatening Age-Related Macular Degeneration

Areas of expertise

Retina: Identification of phenotypes and biomarkers of retinal disease progression Testing new methods of early diagnosis of macular edema and retinal vascular disease Characterisation of responders and non-responders to new available therapies of retinal disease Characterization of phenotypes of diabetic retinopathy Neurovascular degeneration in age-related disease   Glaucoma: Evaluation of new drugs for glaucoma treatment   Other: Optical Coherence Tomography in the diagnosis of neurological diseases Diagnostic correlations in imaging between brain and retina Eye fundus imaging as a predictor of systemic vascular disease Neurovascular degeneration in age-related disease

  • Director

    Inês Marques

  • Investigator

    André Coutinho

    Andreia Rosa

    Conceição Lobo

    Filipe Mira Ferreira

    Inês Laíns

    Inês Pereira Marques

    Isabel Pires

    João Figueira

    João Pedro Marques

    Joana Costa

    Joaquim Neto Murta

    José Costa

    Lisa-Marie Anders

    Luís Silva Pires

    Marco Marques

    Maria Cristina Santos

    Maria Fonseca

    Maria Gonçalo

    Maria João Quadrado

    Maria Luísa Ribeiro

    Maria Luz Cachulo

    Pedro Faria

    Philipp Anders

    Rufino Silva

    Vítor Pinheiro

  • Laboratory Technician

    Filipe Martins

    Inês Rego

  • Study Coordinator

    Catarina Eloy

    Filipe Martins

    Marcela Pascoal

    Sandra Cristina Pardal

  • Technician for Diagnostic Procedures

    Ana Almeida

    Ana Francisca Almeida

    Ana Nunes

    Ana Rocha

    Ana Rita Santos

    Beatriz Lopes Maia

    Inês Pinto

    Marta Lopes

  • Nurse

    Aida Cristina Vitorino

    Andreia Marques

    Denise Domingues

    Eugénia Cardoso

    Maria do Céu Simões

    Paulo Marques

    Tânia Mesquita

  • Pharmacist

    Joana Abrantes

    Patrícia Barreto

  • Secretary

    Sandra Cristina Pardal

  • Director Assistant

    Patrícia Barreto

  • Clients

    ‣ Alcon

    ‣ Alimera

    ‣ Allergan

    ‣ Bausch & Lomb

    ‣ Bayer

    ‣ Chiltern

    ‣ Eurotrials

    ‣ EyeTech

    ‣ Farmalabor

    ‣ IRIS Pharma

    ‣ Lilly

    ‣ Merck Sharp & Dohme

    ‣ Novartis

    ‣ OM Pharma

    ‣ Pfizer

    ‣ Pharmaceutical Product Development

    ‣ Pharmacia Corporation

    ‣ Sanofi-Aventis

    ‣ Servier

    ‣ Théa